12/13/2024
3:16 PM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/11/2024
3:28 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Kurtoglu Metin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
3:21 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kurtoglu Metin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/09/2024
3:36 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kurtoglu Metin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024
5:03 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2024
5:50 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Jewell Christopher M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
5:51 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Singer Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/21/2024
5:52 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Kurtoglu Metin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
3:45 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kurtoglu Metin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
8:44 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
SPRINGER TIMOTHY A (Filed by)
| Form SC 13D/A | |
11/18/2024
6:28 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Miljkovic Milos (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
6:32 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Kurtoglu Metin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
6:35 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
6:23 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Jewell Christopher M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
3:24 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kurtoglu Metin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2024
4:07 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kurtoglu Metin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024
6:31 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/07/2024
6:06 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
6:19 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/15/2024
3:53 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Kalayoglu Murat (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
3:30 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kalayoglu Murat (Filed by)
| Form SC 13D/A | |
10/15/2024
3:43 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Hoge Elizabeth (Reporting)
Seven One Eight Three Four Irrevocable Trust (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
5:08 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
SPRINGER TIMOTHY A (Filed by)
| Form SC 13D/A | |
10/04/2024
4:58 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
11:15 PM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form EFFECT | |
10/01/2024
3:36 PM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 424B7 | |
09/27/2024
3:13 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
3:20 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
SPRINGER TIMOTHY A (Filed by)
| Form SC 13D/A | |
09/26/2024
6:02 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
6:03 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
3:17 PM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form S-1/A | |
08/16/2024
3:02 PM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form DEF 14A | |
08/14/2024
3:41 PM | BARABE TIMOTHY C (Reporting)
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
3:43 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
8:40 AM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
08/08/2024
6:04 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:07 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2024
6:45 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form PRE 14A | |
08/02/2024
6:34 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
07/17/2024
10:45 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/12/2024
5:12 PM | Artal International S.C.A. (Filed by)
Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
| Form SC 13G/A | |
Do this Before Elon’s Reveal on January 22nd (Ad) Elon’s newest tech could pay you an extra $30,000 a year — while you sleep.
It’s smaller than a quarter but designed to power a $9 trillion AI revolution.
And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now. |
07/05/2024
3:02 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2024
3:15 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
SPRINGER TIMOTHY A (Filed by)
| Form SC 13D/A | |
07/02/2024
5:30 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
6:54 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
6:08 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
9:03 AM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
05/08/2024
6:03 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:06 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024
8:09 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024
6:57 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form DEFA14A | |
04/26/2024
6:57 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form DEFA14A | |
04/22/2024
5:25 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
3:49 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
English Emily (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/12/2024
3:24 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
SPRINGER TIMOTHY A (Filed by)
| Form SC 13D/A | |
04/10/2024
8:47 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Singer Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:35 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Jewell Christopher M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:40 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:43 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Kalayoglu Murat (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:30 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Kurtoglu Metin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:33 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Miljkovic Milos (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:20 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Hoge Elizabeth (Reporting)
Seven One Eight Three Four Irrevocable Trust (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:25 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Singer Michael (Filed by)
| Form SC 13D/A | |
04/10/2024
3:29 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kalayoglu Murat (Filed by)
| Form SC 13D/A | |
04/09/2024
6:00 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
3:32 PM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
4:27 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
SPRINGER TIMOTHY A (Filed by)
| Form SC 13D/A | |
03/26/2024
3:32 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
4:09 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
4:29 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
6:55 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
7:19 AM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
03/07/2024
6:06 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
6:08 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/05/2024
6:05 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
4:27 PM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form DEFA14A | |
02/14/2024
3:42 PM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form DEF 14A | |
02/14/2024
11:38 AM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
MANGROVE PARTNERS IM, LLC (Filed by)
| Form SC 13G/A | |
02/09/2024
4:13 PM | Artal International S.C.A. (Filed by)
Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
7:50 AM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
01/31/2024
3:30 PM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form PRE 14A | |
01/23/2024
3:05 PM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K/A | |
01/08/2024
7:45 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
4:08 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Davis Blaine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
4:12 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Singer Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
